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Abstract
Background: Histamine released from mast cells, through complex interactions involving the binding of IgE to
FcεRI receptors and the subsequent intracellular Ca2+ signaling, can mediate many allergic/inflammatory responses.
The possibility of titanium dioxide nanoparticles (TiO2 NPs), a nanomaterial pervasively used in nanotechnology and
pharmaceutical industries, to directly induce histamine secretion without prior allergen sensitization has remained
uncertain.
Results: TiO2 NP exposure increased both histamine secretion and cytosolic Ca
2+ concentration ([Ca2+]C) in a dose
dependent manner in rat RBL-2H3 mast cells. The increase in intracellular Ca2+ levels resulted primarily from an
extracellular Ca2+ influx via membrane L-type Ca2+ channels. Unspecific Ca2+ entry via TiO2 NP-instigated
membrane disruption was demonstrated with the intracellular leakage of a fluorescent calcein dye. Oxidative stress
induced by TiO2 NPs also contributed to cytosolic Ca
2+ signaling. The PLC-IP3-IP3 receptor pathways and
endoplasmic reticulum (ER) were responsible for the sustained elevation of [Ca2+]C and histamine secretion.
Conclusion: Our data suggests that systemic circulation of NPs may prompt histamine release at different locales
causing abnormal inflammatory diseases. This study provides a novel mechanistic link between environmental TiO2
NP exposure and allergen-independent histamine release that can exacerbate manifestations of multiple allergic
responses.
Keywords: TiO2 nanoparticles, mast cell, histamine release, Ca
2+ signaling
Background
Allergic inflammation is a primary pathological feature of
many debilitating diseases [1]. Among the numerous
active mediators and cytokines that modulate initiation
and progression of allergic inflammation, histamine is dis-
tinctly potent [1,2]. Typically, the storage of histamine is
restricted to mast cells and circulating basophils [2,3]. The
cardinal pathway of histamine release involves the attach-
ment of IgE-bound allergens to high-affinity FcεRI recep-
tors on mast cells and the crosslinking of adjacent IgE
molecules by allergens [1,2]. Subsequent receptor cluster-
ing leads to a complex cascade of intracellular Ca2+ signal-
ing resulting from increased activity of phospholipase C
(PLC), generation of diacylglycerol (DAG) (activating
PKC) and inositol 1,4,5-trisphosphate (IP3) which mobi-
lizes the ER Ca2+ store and participates in final histamine
secretion from mast cells. Activation of histamine recep-
tors (H1, H2, H3 and H4) greatly influences inflammatory
responses [2].
Aside from inducing acute allergic inflammatory
responses, histamine also mediates chronic phase pro-
gression by augmenting the secretion of pro-inflamma-
tory cytokines such as IL-1a, IL-1b, and IL-6 as well as
chemokines like RANTES [1,4]. Consequential patholo-
gies are expressed in many systems encompassing ocular,
airway, skin and GI tracts [2]. Associated disorders may
include asthma, allergic rhinitis, allergic conjunctivitis,
atopic dermatitis, urticaria, anaphylaxis and food allergies
[1,4,5]. Possible clinical symptoms include itchiness,
increased vascular permeability, edema, leukocyte infil-
tration, bronchoconstriction and mucus hypersecretion
[1,4,5]. Therefore, any disturbance to the immunological
and/or homeostatic control of histamine release can
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Recently, numerous epidemiological studies have sug-
gested that pollution associated airborne particulate matter
(PM) can aggravate allergic inflammatory responses. Classi-
cal examples of allergies indicate that people with asthma
and rhinitis are more susceptible to the short term acute
effects of particle exposure [6-8]. In line with epidemiologi-
cal studies, results from animal models also demonstrated
that ultrafine particles (one of the major components of
PM) can modulate asthmatic responses by exacerbating
pulmonary inflammation and airway hyper-responsiveness
[9-11]. In an atopic, dermatitis-like, skin lesion mouse
model, exposure to titanium dioxide nanoparticles (TiO2
NPs) was found to worsen symptoms by elevating proin-
flammatory molecules in the skin and increasing serum
levels of IgE and histamine [12]. At the same time, expo-
sure to environmental tobacco smoke has been found to
increase the risks of rhinoconjunctivitis and allergic con-
junctivitis [13,14]. Moreover, Kulig et al reported that pre-
natal and postnatal exposure to environmental tobacco
smoke in children (< 3 yrs old) was associated with sensiti-
zation to food allergens [15]. Despite NPs’ ability to
potentiate allergic responses, the role that histamine plays
in mediation is not clear. More importantly, whether NPs
can directly modulate histamine release from mast cells
without allergen sensitization remains elusive.
TiO2 NPs have been extensively utilized in the nano-
technological and pharmaceutical arenas and are one of
the main components in many household commodities
and personalized products [16,17]. The enormous
annual global production of TiO2 broadens the possibili-
ties of occupational and environmental exposures [18].
As a common constituent of PM10, TiO2 NPs are
widely known for their potential hazardous effects,
which manifest biologically via inflammatory responses
[19]. TiO2 NPs size, surface area and crystalline struc-
ture ascribe cellular nanotoxicity [20-23]. In addition to
respiratory inhalation, NPs can enter the human body
via alternative routes such as: direct penetration through
skin, ingestion and injection [24]. Animal studies have
shown that intra-tracheally instilled TiO2 and other NPs
can possibly transmigrate from lung to systemic circula-
tion [25-27]. Upon entering blood circulation, NPs can
infiltrate multiple organs, potentially directly stimulating
mast cells, a critical effector, exacerbating pathological
consequences [24]. As such, TiO2 NPs were selected as
ideal model particles for our study.
Previously, we have demonstrated that TiO2 NPs can
trigger a cascade of cytosolic Ca2+ signaling leading to
mucin secretion [17]. In the present study, we aim to
investigate the impact of NPs on histamine secretion
from RBL-2H3 mast cells. We hypothesize that TiO2
NPs can directly induce histamine release without prior
allergen sensitization via a Ca2+-mediated pathway.
Results
TiO2 NP characterization
Dynamic laser scattering (DLS) was used to characterize
the TiO2 NPs in suspension. The particle size in Hanks’
solution had a distribution of ~6 to 100 nm due to
minor aggregation while the predominant size was ~83
nm (Figure 1A). Transmission electron microscopy
(TEM) provided detailed characterization of TiO2 NP
size where the mean particle diameter was found to be
60 ± 10 nm (Figures 1B and 1C).
TiO2 NP-Induced [Ca
2+]C increase
We tested whether TiO2 NPs could trigger [Ca
2+]C
increase by loading RBL-2H3 cells with Rhod-2 AM
dye and exposing them to 0.1 mg/ml-1 mg/ml of TiO2
NPs. The TiO2 concentration range used in our study
is consistent with the concentrations found in ambient,
nanotechnology industries and existing literatures
[17,20,28]. The changes in [Ca2+]C were measured by
monitoring the intracellular fluorescence intensity.
Figure 2A shows that 1 mg/ml induced an approximate
160% increase, while lower TiO2 NP concentrations
(< 0.25 mg/ml) caused a smaller elevation, when com-
pared to untreated cells. The results demonstrated a
TiO2 NP concentration dependent increase in [Ca
2+]C
(Figure 2A).
Extracellular source of [Ca2+]C increase
The source of elevated [Ca2+]C was identified by stimulat-
ing RBL-2H3 cells with TiO2 NPs in Ca
2+-free Hanks’
buffer with EGTA added to chelate traces of Ca2+. Figure
2B demonstrates that TiO2 NPs (0.1 mg/ml-1 mg/ml)
failed to induce a significant increase in [Ca2+]C, when
compared with the 160% increase observed in normal
Hanks’ buffer (Figure 2A). Our data suggested that the
extracellular Ca2+ pool was the primary source of the
observed [Ca2+]C increase. We then examined if TiO2
NPs can induce extracellular Ca2+ influx via membrane
channels, in particular L-type Ca2+ channels. Blocking
the channels with CdCl2 (200 μM) markedly inhibited
the rise in [Ca2+]C by approximately 75% (Figure 2C).
Subsequent pre-treatment of cells with nifedipine or ver-
apamil (L-type Ca2+ channel blockers) also hampered the
rise in [Ca2+]C elicited by TiO2 NPs (Figure 2D and 2E).
Nonetheless, the incomplete blockage of Ca2+ influx with
membrane channel blockers suggests a possible Ca2+
leakage through perturbed cell membranes. To confirm
that TiO2 NPs can instigate membrane disruption,
thereby permitting unspecific extracellular Ca2+ entry, a
fluorescent calcein dye was used to assess cytosolic leak-
age. Results showed a dye permeation ratio increase from
approximately 5 to 12% with a TiO2 NP concentration
ranging from 0.1 to 1 mg/ml (Figure 2F).
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Induction of oxidative stress and associated Ca2+ influx
Demonstrating possible effects of oxidative stress evoked
by TiO2 NPs, intracellular ROS formation was investi-
gated. Transient exposure of RBL-2H3 cells to TiO2 NPs
for 15 min resulted in cytosolic ROS level increase in a
dose-dependent manner (Figure 3A). Since oxidative stress
can trigger intracellular Ca2+ signaling, cells pretreated
with an antioxidant NAC were monitored for changes in
[Ca2+]C upon TiO2 stimulation. Our data revealed that
NAC notably attenuated the increase in [Ca2+]C triggered
by TiO2 NPs (Figure 3B).
The IP3-IP3 receptor as a histamine-release pathway
To understand the influence of PLC, and the ensuing IP3-
IP3 receptor pathway on cytosolic Ca
2+, the RBL-2H3 cells
were pre-treated with U73122 (PLC inhibitor), 2-APB or
Xestospongin (IP3 receptor blockers), before being
exposed to TiO2 NPs. The data revealed a > 75% drop in
the [Ca2+]C after TiO2 NP stimulation (Figure 4A-C).
Since ER is one of the main intracellular Ca2+ stores, it
is highly responsible for the amplification of intracellular
Ca2+ signals. Thapsigargin was used to deplete intracellu-
lar ER Ca2+ pool and caused a decrease in the [Ca2+]C
after TiO2 NP exposure (Figure 4D).
Ca2+ dependency of TiO2 NP-induced histamine secretion
ELISA was used to assess the amount of histamine
secreted from RBL-2H3 cells when stimulated with TiO2
NPs. Comparing with the control, TiO2 NPs increased his-
tamine secretion in a dose-dependent fashion (Figure 5A).
Incubation with BAPTA-AM (intracellular calcium chela-
tor), Thapsigargin, U73122, 2-APB or Xestospongin signif-
icantly attenuated histamine secretion (Figure 5B). Our
data indicated that histamine release is attributed to a high
[Ca2+]C sustained by an external Ca
2+ influx and a second-
ary Ca2+ release from intracellular Ca2+ stores (organelles).
Discussion
Recently, a growing epidemic of exacerbated allergic
inflammatory diseases have been closely linked with the
exposure to airborne PM pollution [5,7,8]. Many prior
investigations have focused on the hazardous effects of
NPs. These reports have primarily been either epidemiolo-
gical studies that draw correlations between clinical mani-
festations and exposure to environmental pollutants or
immunological studies that examine the release of inflam-
matory cytokines and subsequent recruitment of immune
cells using allergen-sensitized mice with PM or NP insults
[7,9,10]. Few studies have systematically investigated the
role of histamine secretion from mast cells during NP chal-
lenge and its role in mediating allergic inflammation. By
using allergen-sensitized animal models, these studies over-
looked the NP’s potential to directly stimulate histamine
release from mast cells without prior allergen sensitization
or IgE production. In addition, the associated underlying
cellular mechanisms leading to the final degranulation are
not clear. TiO2 NPs have previously been shown to trigger
mucin secretion, pulmonary inflammatory responses and
emphysema-like pathology [17,18,29,30]. In this study, we
demonstrate that TiO2 NPs can directly stimulate hista-
mine release from RBL-2H3 mast cells via a Ca2+- depen-
dent pathway.
Allergic inflammatory diseases encompass a multifactor-
ial interplay between many elements/systems; our study
focuses on how TiO2 NPs can directly trigger histamine
release from mast cells and its potential to exacerbate
allergic symptoms. This effect is due to histamine’s ability
to affect the physiology and pathology of a wide range of
cells via corresponding receptors that are widely expressed
on airway and vascular muscle cells, hepatocytes, chondro-
cytes, endothelial cells, epithelial cells, neutrophil, eosino-
phils, monocytes, macrophage, dendritic cells, and T and
B cells [4]. We found that TiO2 NPs can significantly
Figure 1 TiO2 NP characterization using DLS and TEM. (A) DLS assessment of TiO2 NP in Hanks’ solution revealed a size distribution of ~6 to
100 nm. (B) A representative TEM image of the TiO2 NPs with an average diameter of 60 ± 10 nm (n = 300). (C) A bar graph showing the size
distribution of TiO2 NPs based on TEM images (n = 300).
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Figure 2 Measurement of the [Ca2+]C and calcein leakage after TiO2 NP exposure. (A) RBL-2H3 cells were stimulated with TiO2 NPs with
concentrations of 0.1 mg/ml (orange), 0.25 mg/ml (green), 0.5 mg/ml (purple), 0.75 mg/ml (blue) and 1 mg/ml (red) in normal Hanks’ solution,
(B) in Ca2+-free Hanks’ solution, (C) in the presence of CdCl2 (200 μM), (D) nifedipine (10 μM), (E) verapamil (100 μM), and (F) calcein (50 μM) (n ≥
12, **p < 0.005) (all colors are as depicted in Figure 2A and each line is a representative fluorescence intensity of approximately 200 cells).
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induce histamine release from RBL-2H3 cells in a dose
dependent manner (Figure 5A). Our data is corroborated
by evidence documenting more severe TiO2 NP-induced
inflammation with elevated release of inflammatory cyto-
kines than that of TiO2 of micrometric dimensions
[31,32]. The TiO2 NP-elicited mast cell degranulation also
appeared to be a Ca2+-dependent process, as indicated by
a major attenuation in histamine secretion when pre-
treated with BAPTA (Figure 5B). The importance of Ca2+
in stimulus-secretion coupling mechanisms is well docu-
mented [33,34]. We and others have reported that NPs
increase [Ca2+]C prior to cellular exocytosis [17,35]. As
TiO2 concentrations increased from 0.1 to 1 mg/ml, a sus-
tained elevation in [Ca2+]C was observed (Figure 2A). Our
data demonstrated that [Ca2+]C increased as a function of
TiO2 concentration and coincided with the measurements
of histamine secretion (Figure 5A). The TiO2 NPs used in
our study consisted of a mixture of anatase/rutile crystal-
line forms which have been shown to impose greater cellu-
lar toxicity [22]. Although phase composition, surface
chemistry and purity may play important roles in influen-
cing nanotoxicity, dependence on additional physical para-
meters such as particle size, surface area and concentration
have all been reported [20,21,36-38]. However, the
mechanism by which TiO2 NPs trigger intracellular mast
cell Ca2+ signaling is not clear.
Previous experimental evidence suggests that ultrafine
carbon black and ZnO NPs can induce extracellular Ca2+
influx through activated voltage-gated Ca2+ channels
[35,39]. The question of whether TiO2 NPs can trigger a
similar process is unclear. Our experiments confirmed
that [Ca2+]C failed to increase significantly when cells
were treated with TiO2 NPs in Ca
2+-free Hanks’ solution
(Figure 2B) or blocked with CdCl2 (a general Ca
2+
channel blocker) (Figure 2C) [17]. We then demonstrated
that TiO2 NPs can activate L-type voltage-gated Ca
2+
channels on mast cells, allowing extracellular Ca2+ influx
into the cytosol (Figure 2D and 2E). The ROS generated
in response to NP exposure has been attributed to the
opening of membrane Ca2+ channels [17,35,39,40]. Our
data revealed that TiO2 NPs elevated cytosolic ROS levels
(Figure 3A) and that the involvement of oxidative stress
could modulate intracellular Ca2+ homeostasis by activat-
ing L-type Ca2+ channels (Figure 3B). Supporting our
results, Hussain and colleagues also reported that TiO2
NPs can exert oxidative effects under abiotic conditions
[23]. Other studies have shown that TiO2 NPs increase
intracellular ROS production in various cells by causing
mitochondrial injuries, such as impaired mitochondrial
membrane permeability, a decrease in mitochondrial
potential, mitochondrial respiratory dysfunction and
downregulation of SOD (superoxide dismutase) and GSH
(glutathione) levels [41,42]. ROS are thought to affect
Ca2+ signaling possibly by oxidation of thiol groups of
membrane channels and changing the intra-molecular
bonding of proteins and lipids [43,44]. Moreover, it has
been suggested that ROS can impact membrane Ca2+
channels and Ca2+ binding proteins [43]. In addition to
ROS formation, direct damage to cell membrane integrity
by lipid peroxidation may be an alternative route for
extracellular Ca2+ entry [22,39]. Co-administration of
TiO2 NPs and fluorescent calcein dye resulted in an aug-
mented calcein permeation ratio (Figure 2F). The calcein
data corroborates with previous publications showing
that TiO2 NPs can perturb the lipid bilayer, perhaps by
forming transient pores that may account for the portion
of Ca2+ increase that could not be completely abolished
by blocking L-type Ca2+ channels [17,45].
Figure 3 Measurement of intracellular ROS level and the associated changes in [Ca2+]C. (A) RBL-2H3 cells were exposed to TiO2 NPs at
concentrations 0, 0.1, 0.25, 0.5 and 0.75 mg/ml. The generation of ROS was measured by fluorescence imaging. The level of ROS increased as a
function of increasing TiO2 NP concentration (n ≥ 50, **p < 0.005). (B) Pretreatment with antioxidant NAC (250 μM) significantly reduced the rise
in cytosolic Ca2+ when stimulated with TiO2 NPs. Each line is a representative fluorescence intensity of approximately 200 cells and the colors
used are consistent with Figure 2A.
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An initial upsurge in [Ca2+]C from extracellular influx is
usually relayed by a secondary Ca2+ release from internal
organelles [46]. However, the question of how TiO2 NPs
transduce Ca2+ signals in mast cells involving common sec-
ondary messengers remains unanswered. Heretofore, we
demonstrated that TiO2 NPs could stimulate PLC and IP3
receptor activities in mast cells, resulting in secondary
amplification of cytosolic Ca2+. Data from Figure 4A-C
showed that cells incubated with U73122, 2-APB and Xes-
tospongin notably inhibited TiO2 NP-triggered Ca
2+ rise
and histamine secretion (Figure 5B). Activation of PLC can
be explained by the stimulation from ROS [47,48]. Alterna-
tively, a localized increase in [Ca2+]C has been shown to
trigger PLC, thereby generating IP3 and DAG [49]. Collec-
tively, these results point toward the contribution from ER
Ca2+ stores. Figure 4D revealed that depleting the ER inter-
nal store with Thapsigargin significantly diminished TiO2
NPs stimulated cytosolic Ca2+ increase and subsequent his-
tamine secretion (Figure 5B). Our data indicates that the
ER dependent IP3-IP3 receptor pathway is critically
involved in amplifying (or sustaining) the initial cytosolic
Ca2+ rise and subsequent histamine release.
Conclusion
Our findings revealed a new mechanism depicting how
TiO2 NPs can potentially exacerbate many allergic inflam-
matory responses and perhaps non-allergic inflammatory
disorders. Mast cell exposure to TiO2 NPs can activate
membrane L-type Ca2+ channels, induce ROS production
and stimulate PLC activity. Influx of extracellular Ca2+
Figure 4 Measurement of [Ca2+]C after stimulation by TiO2 NPs. RBL-2H3 cells were stimulated with TiO2 NPs with concentrations that vary
from 0.1 mg/ml-1 mg/ml, in the presence of (A) U73122 (10 μM), (B) 2-APB (50 μM) and (C) Xestospongin (20 μM) and (D) Thapsigargin (100
nM). The colors used are in accordance with Figure 2A. Each line represents the average fluorescent intensity of more than 200 cells.
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raises [Ca2+]C, and when coupled with the IP3-IP3 receptor
pathway, can trigger the release of ER resident Ca2+ and
subsequent histamine secretion. These results suggest that
mast cell degranulation of histamine may be significantly
augmented and intensified in NP exposed tissues with or
without IgE antibody-based sensitization. This model may
also provide a new explanation for chronic inflammatory
diseases elicited by airborne PM. The inhaled NPs can cir-
culate and accumulate in various organs thereby elevating
the risks of activating mast cell degranulation in other tis-
sues [25,50,51]. As a result, NP exposure may worsen the
mast cell associated inflammatory symptoms involving
arthritis, atherosclerosis and coronary diseases [52-54].
Finally, our results suggest that a new immunoregulatory
system may be considered since NPs can directly trigger
inflammatory mediators, thereby bypassing traditional
immuno-stimulation by allergens.
Methods
Culture of RBL-2H3 Mast Cells
The RBL-2H3 rat mast cell line (ATCC, Manassas, VA,
USA) is a widely-used mast cell model that responds to
stimuli by secreting histamine and other mediators [55].
RBL-2H3 cells elicit a potent immune allergic response
following crosslinking of their IgE-bound FcεRI by mul-
tivalent allergens [55]. Cells were cultured in 15 cm cell
culture plates (VWR, CA, USA) in MEM medium (Invi-
trogen, CA, USA) supplemented with L-glutamine, 1%
penicillin/streptomycin and 10% heat inactivated fetal
bovine serum (FBS) (Invitrogen, CA, USA). Cultures
were incubated in a humidified incubator at 37°C/5%
CO2. Cell counts were performed using trypan blue
(Sigma-Aldrich, MO, USA) exclusion and a Bright-Line
haemocytometer.
Nanoparticles and Characterization
A mixture of anatase and rutile forms of ultrafine tita-
nium (IV) dioxide (< 100 nm diameter by Brunauer
Emmett Teller (BET) method, purity of 99.5% trace
metals basis) (Cat No. 634662) (Sigma-Aldrich, MO,
USA) was used in this study because this form has been
shown to result in more severe cellular injuries [22]. The
TiO2 NPs have a primary crystalline size of 100 nm
(maximum), specific surface area of 46.3 m2/g (as deter-
mined by BET), equivalent spherical diameter of 100 nm
(maximum) and a trace metallic impurities of 1000 ppm
(maximum) (information from Sigma). All TiO2 NP sam-
ples were reconstituted in Hanks’ buffer (Invitrogen, CA,
USA) and sonicated for approximately 1 minute immedi-
ately before usage. The concentrations used were 1 mg/
ml, 0.75 mg/ml, 0.5 mg/ml, 0.25 mg/ml, and 0.1 mg/ml.
All sizes of NP suspension were independently confirmed
using homodyne dynamics laser scattering (DLS) as
described in the previous study [17]. Morphology and
size of TiO2 NP powder were determined by transmis-
sion electron microscope (JEOL JEM-2010 HRTEM, MA,
USA) and analyzed using an analysisPRO (Olympus, PA,
USA).
Cell Preparation
Cells were seeded at 1 × 105 cells per well in a 24-well
plate, and incubated for 24 hrs in MEM medium sup-
plemented with 10% FBS. Following 24 hr incubation,
the MEM medium was removed from the cells and the
Figure 5 Measurement of histamine secretion evoked by TiO2 NPs. (A) ELISA quantification of histamine release from RBL-2H3 cells after
TiO2 NP (0.1 mg/ml-0.75 mg/ml stimulation) in normal Hanks’ solution (n ≥ 3, **p < 0.005). (B) Subsequent assessment of histamine secretion
from RBL-2H3 cells when pre-treated with an intracellular Ca2+ chelator (BAPTA) and various blockers prior to TiO2 NP exposure (n ≥ 3; white,
checkboard, and black bars represent 0, 0.5 and 0.75 mg/ml, respectively).
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culture was rinsed with Hanks’ solution twice before
use.
Measurement of cytosolic Ca2+ concentrations induced by
TiO2 exposure
All experiments were performed in dark conditions. The
cells were loaded with a Rhod-2 AM dye (1 μM) (Kd = 570
nM, lEx = 552 nm and lEm = 581) (Invitrogen, CA, USA)
for 45 minutes. After the dye loading, the cells were rinsed
and incubated with either normal Hanks’ or Ca2+-free
Hanks’ solution, and treated with the appropriate TiO2
NP concentrations. All Ca2+ signaling experiments were
carried out on a thermoregulated stage at 37°C mounted
on a Nikon microscope (Nikon Eclipse TE2000- U, Tokyo,
Japan). RBL-2H3 cells were then incubated with cadmium
chloride (200 μM; Sigma-Aldrich, MO, USA) to block the
membrane Ca2+ channels [17], followed by TiO2 NP sti-
mulation. To test the interaction between TiO2 and L-type
membrane Ca2+ channels, nifedipine (10 μM; Sigma-
Aldrich, MO, USA) and verapamil (100 μM; Sigma-
Aldrich, MO, USA), L-type Ca2+ channel blockers [17,39]
were applied to RBL-2H3 cells, independently, prior to the
exposure of TiO2. Antioxidant N-acetylcysteine (NAC,
250 μM; Sigma-Aldrich, MO, USA) was also added to
RBL-2H3 cells to study the involvement of reactive oxygen
species (ROS) [17,39], possibly generated as a result of
TiO2 stimulation, and the activation of Ca
2+ channels.
Thapsigargin (100 nM; Sigma-Aldrich, MO, USA) was used
to deplete the ER Ca2+ content in order to investigate the
contribution of the internal ER Ca2+ pool [17,56]. In order
to test the involvement of secondary messenger molecules
in intensifying a Ca2+ response, U73122 (PLC blocker)
(10 μM; Sigma-Aldrich, MO, USA), Aminoethoxydiphenyl
borate (2-APB) (50 μM; Sigma-Aldrich, MO, USA) and
Xestospongin C (IP3 receptor blockers) (20 μM; VWR, CA,
USA) were pre-incubated with cells prior to TiO2 NP expo-
sure [56,57].
Calcein dye leakage measurements
RBL-2H3 cells were seeded at a density of 1 × 105 cells per
well in a 24-well plate and cultured for 24 hrs. TiO2 pre-
pared with calcein fluorescent dye (50 μM) (Invitrogen,
CA, USA) in Hanks’ buffer was incubated with the cells
for 5 minutes at 37°C. Calcein is a biological inert green-
fluorescent molecule of a molecular mass of 623 Daltons
and an estimated molecular radius of 0.6 nm [17]. The
TiO2 NP solution containing calcein dye was then
removed and the cells were rinsed twice with PBS to
remove any possible remnants of the dye. Subsequently,
the cells were loaded with Hoechst (10 μM) (Sigma-
Aldrich, MO, USA), a fluorescent nucleus dye, for 5 min-
utes at 37°C, and were then rinsed thoroughly [17]. Fresh
Hanks’ solution was added into each well before taking
fluorescent images of calcein and Hoechst loaded cells
with a Nikon fluorescence microscope. Afterwards, a per-
centage of calcein loaded cells against total number of
cells, as determined by the Hoechst dye, was calculated for
each of the TiO2 NP concentrations used in the
experiment.
Intracellular reactive oxygen species (ROS) production
ROS production was evaluated by fluorescence micro-
scopy using oxidation of CM-H2DCFDA dye (Invitrogen,
CA, USA). The cells (1 × 105 cells/well) were cultured for
24 hrs before being rinsed with PBS solution. Hanks’ buf-
fer, containing TiO2 NPs at concentrations ranging from
0-0.75 mg/ml, was then incubated with the cells for 15
minutes in 37°C followed by PBS washing and loading
with 2 μM CM-H2DCFDA dye for 30 minutes. Fluores-
cent images of ROS generated in cells were captured and
analyzed by calculating the ratio of increase in fluorescent
intensity between TiO2 NP treatment and control groups.
Histamine detection with enzyme linked immunosorbent
assay (ELISA) preparation
The cells were seeded at a density of 1 × 105 cells den-
sity in a 24-well plate and cultured for 24 hrs. RBL-2H3
cells were then rinsed with PBS and pre-treated with
BAPTA-AM (50 μM) (Invitrogen, CA, USA), Thapsigar-
gin (SERCA pump inhibitor), U73122, 2-APB, or Xestos-
pongin for 20 minutes in the same manner. Cells were
stimulated for 5 minutes with the appropriate TiO2 NP
concentrations (0-0.75 mg/ml) which were prepared in
PBS. The histamine-containing supernatant was col-
lected and centrifuged to remove any remaining TiO2
NPs. The supernatant was then incubated in a 96-well
plate overnight at 4°C. The rest of the assay was carried
out in accord to Neogen ELISA instructions pertaining
to the histamine kit (Neogen Corp, MI, USA).
Image Analysis
After staining the treated cells, image analysis was per-
formed with an inverted Nikon Eclipse TE2000-U fluor-
escent microscope. Each photo was taken at a
magnification of 200 × and analyzed using SimplePCI
(Compix Inc., Imaging Systems, Sewickle, PA, USA).
The data shown is a representative of Ca2+ signals of
more than 200 cells and the experiments were con-
ducted independently for at least 3 times.
Statistical Analysis
The data was presented as means ± SD. Each experi-
ment was performed independently at least three times.
Statistical significance was determined using a Student’s
t-test analysis with p values < 0.05 (GraphPad Prism 4.0,
GraphPad Software, Inc., San Diego, CA, USA).
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